Gas6 induces proliferation in prostate carcinoma cell lines expressing the Axl receptor

Journal of Cellular Physiology

Volumn 204, Issue 1, 2005, Pages 36-44

  Sainaghi, Pier Paolo ^a   Castello, Luigi ^a   Bergamasco, Luca ^a   Galletti, Margherita ^b   Bellosta, Paola ^b   Avanzi, Gian Carlo ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AXL RECEPTOR; GROWTH ARREST SPECIFIC PROTEIN 6; MITOGEN ACTIVATED PROTEIN KINASE; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL PROLIFERATION; COLON CANCER; CONTROLLED STUDY; ENDOMETRIUM CANCER; ENZYME PHOSPHORYLATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LEUKEMIA; MELANOMA; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; THYROID CANCER;

1-PHOSPHATIDYLINOSITOL 3-KINASE; APOPTOSIS; CELL DIVISION; CELL LINE, TUMOR; CULTURE MEDIA, SERUM-FREE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MAP KINASE SIGNALING SYSTEM; ONCOGENE PROTEINS; PHOSPHORYLATION; PROSTATIC NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR PROTEIN-TYROSINE KINASES;

EID: 20144384673     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20265     Document Type: Article

References (68)

1. Allen MP, Zeng C, Schneider K, Xiong X, Meintzer MK, Bellosta P, Basilico C, Varnum B, Heidenreich KA, Wierman ME. 1999. Growth arrest-specific gene 6 (Gas6)/adhesion related kinase (Ark) signaling promotes gonadotropin-releasing hormone neuronal survival via extra cellular signal-regulated kinase (ERK) and AKT. Mol Endocrinol 13:191-201.
2. Avanzi GC, Gallicchio M, Cavalloni G, Gammaitoni L, Leone F, Rosina A, Boldorini R, Monga G, Pegoraro L, Varnum B, Aglietta M. 1997. GAS6, the ligand of Axl and Rse receptors, is expressed in hematopoietic tissue but lacks mitogenic activity. Exp Hematol 25:1219-1226.
3. Avanzi GC, Gallicchio M, Bottarel F, Gammaitoni L, Cavalloni G, Buonfiglio D, Bragardo M, Bellomo G, Albano E, Fantozzi R, Garbarino G, Varnum B, Aglietta M, Saglio G, Dianzani U, Dianzani C. 1998. GAS6 inhibits granulocyte adhesion to endothelial cells. Blood 91:2334-2340.
4. Bastola DR, Pahwa GS, Lin MF, Cheng PW. 2002. Downregulation of PTEN/ MMAC/TEP1 expression in human prostate cancer cell line DU 145 by growth stimuli. Mol Cell Biochem 236:75-81.
5. Bellosta P, Costa M, Lin DA, Basilico C. 1995. The receptor tyrosine kinase ARK mediates cell aggregation by homophilic binding. Mol Cell Biol 15:614-625.
6. Bellosta P, Zhang Q, Goff SP, Basilico C. 1997. Signaling through the ARK tyrosine kinase receptor protects from apoptosis in the absence of growth stimulation. Oncogene 15:2387-2397.
7. Berclaz G, Altermatt HJ, Rohrbach V, Siragusa A, Dreher E, Smith PD. 2001. EGFR dependent expression of STATS (but not STAT1) in breast cancer. Int J Oncol 19:1155-1160.
8. Bittner M, Meltzer P, Chen Y, Jiang Y, Seftor E, Hendrix M, Radmacher M, Simon R, Yakhini Z, Ben-Dor A, Sampas N, Dougherty E, Wang E, Marincola F, Gooden C, Lueders J, Glatfelter A, Pollock P, Carpten J, Gillanders E, Leja D, Dietrich K, Beaudry C, Berens M, Alberts D, Sondak V. 2000. Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 406:536-540.
9. Bogenrieder T, Herlyn M. 2003. Axis of evil: Molecular mechanisms of cancer metastasis. Oncogene 22:6524-6536.
10. Braunger J, Schleithoff L, Schulz AS, Kessler H, Lammers R, Ullrich A, Bartram CR, Janssen JW. 1997. Intracellular signaling of the Ufo/Axl receptor tyrosine kinase is mediated mainly by a multi-substrate docking-site. Oncogene 14:2619-2631.
11. Burchert A, Attar EC, McCloskey P, Fridell YW, Liu ET. 1998. Determinants for transformation induced by the Axl receptor tyrosine kinase. Oncogene 16:3177-3187.
12. Carson JP, Kulik G, Weber MJ. 1999. Antiapoptotic signaling in LNCaP prostate cancer cells: A survival signaling pathway independent of phosphatidvlinositol 3′-kinase and AKT/protein kinase B. Cancer Res 59:1449-1453.
13. Chen X, Thakkar H, Tyan F, Gim S, Robinson H, Lee C, Pandey SK, Nwokorie C, Onwudiwe N, Srivastava RK. 2001. Constitutively active AKT is an important regulator of TRAIL sensitivity in prostate cancer. Oncogene 20:6073-6083.
14. Chiu SM, Xue LY, Usuda J, Azizuddin K, Oleinick NL. 2003. Bax is essential for mitochondrion-mediated apoptosis but not for cell death caused by photodynamic therapy. Br J Cancer 89:1590-1597.
15. Costa M, Bellosta P, Basilico C. 1996. Cleavage and release of a soluble form of the receptor tyrosine kinase ARK in vitro and in vivo. J Cell Physiol 168:737-744.
16. Craven RJ, Xu LH, Weiner TM, Fridell YW, Dent GA, Srivastava S, Varnum B, Liu ET, Cance WG. 1995. Receptor tyrosine kinases expressed in metastatic colon cancer. Int J Cancer 60:791-797.
17. Davies MA, Koul D, Dhesi H, Berman R, McDonnell TJ, McConkey D, Yung WK, Steck PA. 1999. Regulation of AKT/PKB activity, cellular growth, and apoptosis in prostate carcinoma cells by MMAC/PTEN. Cancer Res 59:2551-2556.
18. Demarchi F, Verardo R, Varnum B, Brancolini C, Schneider C. 2001. Gas6 antiapoptotic signaling requires NF-kappa B activation. J Biol Chem 276:31738-31744.
19. Diehl JA, Cheng M, Roussel MF, Sherr CJ. 1998. Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev 12:3499-3511.
20. Edelman GM, Crossin KL. 1991. Cell adhesion molecules: Implications for a molecular histology. Annu Rev Biochem 60:155-190.
21. Fischer EH, Charbonneau H, Tonks NK. 1991. Protein tyrosine phosphatases: A diverse family of intracellular and transmembrane enzymes. Science 253:401-406.
22. Furnari FB, Huang HJ, Cavenee WK. 1998. The phosphoinositol phosphatase activity of PTEN mediates a serum-sensitive G1 growth arrest in glioma cells. Cancer Res 58:5002-5008.
23. Gallicchio M, Mitola S, Valdembri D, Fantozzi R, Varnum B, Avanzi GC, Bussolino F. 2004. Inhibition of vascular endothelial growth factor receptor 2-mediated endothelial cell activation by Axl tyrosine kinase receptor. Blood [Epub ahead of print].
24. Goruppi S, Ruaro E, Schneider C. 1996. Gas6, the ligand of Axl tyrosine kinase receptor, has mitogenic and survival activities for serum starved NIH3T3 fibroblasts. Oncogene 12:471-480.
25. Goruppi S, Ruaro E, Varnum B, Schneider C. 1997. Requirement of phosphatidylinositol 3-kinase-dependent pathway and Sr c for Gas6-Axl mitogenic and survival activities in NIH 3T3 fibroblasts. Mol Cell Biol 17:4442-4453.
26. Goruppi S, Ruaro E, Varnum B, Schneider C. 1999. Case-mediated survival in NIH3T3 cells activates stress signaling cascade and is independent of Ras. Oncogene 18:4224-4236.
27. Goruppi S, Chiaruttini C, Ruaro ME, Varnum B, Schneider C. 2001. Gas6 induces growth, beta-catenin stabilization, and T-cell factor transcriptional activation in contact-inhibited C57 mammary cells. Mol Cell Biol 21:902-915.
28. Graff JE, Konicek BW, McNulty AM, Wang Z, Houck K, Allen S, Paul JD, Hbaiu A, Goode RG, Sandusky GE, Vessella RL, Neubauer BL. 2000. Increased AKT activity contributes to prostate cancer progression by dramatically accelerating prostate tumor growth and diminishing p27Kip1 expression. J Biol Chem 275:24500-24505.
29. Graham DK, Dawson TL, Mullaney DL, Snodgrass HR, Earp HS. 1994. Cloning and mRNA expression analysis of a novel human proto-oncogene, c-mer. Cell Growth Differ 5:647-657.
30. Hasanbasic I, Cuerquis J, Varnum B, Blostein MD. 2004. Intracellular signaling pathways involved in Gas6-Axl-mediated survival of endothelial cells. Am J Physiol Heart Circ Physiol 3:287-292.
31. Ito T, Ito M, Naito S, Ohtsuru A, Nagayama Y, Kanematsu T, Yamashita S, Sekine I. 1999. Expression of the Axl receptor tyrosine kinase in human thyroid carcinoma. Thyroid 9:563-567.
32. Ito M, Nakashima M, Nakayama T, Ohtsuru A, Nagayama Y, Takamura N, Demedchik EP, Sekine I, Yamashita S. 2002. Expression of receptor-type tyrosine kinase, Axl, and its ligand, Gas6, in pediatric thyroid carcinomas around chernobyl. Thyroid 12:971-975.
33. Jacob AN, Kalapurakal J, Davidson WR, Kandpal G, Dunson N, Prashar Y, Kandpal RP. 1999. A receptor tyrosine kinase, UFO/Axl, and other genes isolated by a modified differential display PCR are over expressed in metastatic prostatic carcinoma cell line DU145. Cancer Detect Prev 23:325-332.
34. Janssen JW, Schulz AS, Steenvoorden AC, Schmidberger M, Strehl S, Ambros PF, Bartram CR. 1991. A novel putative tyrosine kinase receptor with oncogenic potential. Oncogene 6:2113-2120.
35. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. 2003. Cancer statistics, 2003. CA Cancer J Clin 53:5-26.
36. Lai C, Lemke G. 1991. An extended family of protein-tyrosine kinase genes differentially expressed in the vertebrate nervous system. Neuron 6:691-704.
37. Lai C, Gore M, Lemke G. 1994. Structure, expression, and activity of Tyro 3, a neural adhesion-related receptor tyrosine kinase. Oncogene 9:2567-2578.
38. Li DM, Sun H. 1998. PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells. Proc Natl Acad Sci USA 95:15406-15411.
39. Li R, Chen J, Hammonds G, Phillips H, Armanini M, Wood P, Bunge R, Godowski PJ, Sliwkowski MX, Mather JP. 1996. Identification of Gas6 as a growth factor for human Schwann cells. J Neurosci 16:2012-2019.
40. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Pue J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH, Parsons R. 1997. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275:1943-1947.
41. Loeser RF, Varnum BC, Carlson CS, Goldring MB, Liu ET, Sadiev S, Kute TE, Wallin R. 1997. Human chondrocytes expression of growth-arrest-specific gene 6 and the tyrosine kinase receptor Axl: Potential role in autocrine signaling in cartilage. Arthritis Rheum 40:1455-1465.
42. Lu Q, Gore M, Zhang Q, Camenisch T, Boast S, Casagranda F, Lai C, Skinner MK, Klein R, Matsushima GK, Earp HS, Goff SP, Lemke G. 1999. Tyro-3 family receptors are essential regulators of mammalian spermatogenesis. Nature 398:723-728.
43. Manfioletti G, Brancolini C, Avanzi G, Schneider C. 1993. The protein encoded by a growth arrest-specific gene (Gas6) is a new member of the vitamin K-dependent proteins related to protein S, a negative coregulator in the blood coagulation cascade. Mol Cell Biol 13:4976-4985.
44. McMenamin ME, Soung P, Perera S, Kaplan I, Loda M, Sellers WR. 1999. Loss of PTEN expression in paraffin-embedded primary prostate cancer correlates with high Gleason score and advanced stage. Cancer Res 59:4291-4296.
45. Nakamura N, Ramaswamy S, Vazquez F, Signoretti S, Loda M, Sellers WR. 2000. Forkhead transcription factors are critical effectors of cell death and cell cycle arrest downstream of PTEN. Mol Cell Biol 20:8969-8982.
46. Nakano T, Higashino K, Kikuchi N, Kishino J, Nomura K, Fujita H, Ohara O, Arita H. 1995. Vascular smooth muscle cell-derived, Gla-containing growth-potentiating factor for Ca(2+)-mobilizing growth factors. J Biol Chem 270:5702-5705.
47. Nakano T, Kawamoto K, Higashino K, Arita H. 1996. Prevention of growth arrest-induced cell death of vascular smooth muscle cells by a product of growth arrest-specific gene, Gas6. FEBS Lett 387:78-80.
48. Nakano T, Kawamoto K, Kishino J, Nomura K, Higashino K, Arita H. 1997. Requirement of gamma-carboxyglutamic acid residues for the biological activity of Gas6: Contribution of endogenous Gas6 to the proliferation of vascular smooth muscle cells. Biochem J 323:387-392.
49. Nelson WG, De Marzo AM, Isaacs WB. 2003. Prostate cancer. N Engl J Med 349:366-381.
50. Neubauer A, Fiebeler A, Graham DK, O'Bryan JP, Schmidt CA, Barckow P, Serke S, Siegert W, Snodgrass HR, Huhn D, et al. 1994. Expression of axl, a transforming receptor tyrosine kinase, in normal and malignant hematopoiesis. Blood 84:1931-1941.
51. O'Bryan JP, Frye RA, Cogswell PC, Neubauer A, Kitch B, Prokop C, Espinosa E III, Le Beau MM, Earp HS, Liu ET. 1991. Axl, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase. Mol Cell Biol 11:5016-5031.
52. Orr FW, Wang HH, Lafrenie RM, Scherbarth S, Nance DM. 2000. Interactions between cancer cells and the endothelium in metastasis. J Pathol 190:310-329.
53. Pfeil K, Eder IE, Putz T, Ramoner R, Culig Z, Ueberall F, Bartsch G, Klocker H. 2004. Long-term androgen-ablation causes increased resistance to PI3K/AKT pathway inhibition in prostate cancer cells. Prostate 58:259-268.
54. Quong RY, Bickford ST, Ing YL, Terman B, Herlyn M, Lassam NJ. 1994. Protein kinases in normal and transformed melanocytes. Melanoma Res 4:313-319.
55. Ramaswamy S, Nakamura N, Vazquez F, Batt DB, Perera S, Roberts TM, Sellers WR. 1999. Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/AKT pathway. Proc Natl Acad Sci USA 96:2110-2115.
56. Rescigno J, Mansukhani A, Basilico C. 1991. A putative receptor tyrosine kinase with unique structural topology. Oncogene 6:1909-1913.
57. Robinson D, He F, Pretlow T, Kung HJ. 1996. A tyrosine kinase profile of prostate carcinoma. Proc Natl Acad Sci USA 93:5958-5962.
58. Rothermund CA, Kondrikov D, Lin MF, Vishwanatha JK. 2002. Regulation of Bcl-2 during androgen-unresponsive progression of prostate cancer. Prost Cancer Prost Diseases 5:236-245.
59. Schneider C, King RM, Philipson L. 1988. Genes specifically expressed at growth arrest of mammalian cells. Cell 54:787-793.
60. Shankar SL, O'Guin K, Cammer M, McMorris FA, Stitt TN, Basch RS, Varnum B, Shafit-Zagardo B. 2003. The growth arrest-specific gene product Gas6 promotes the survival of human oligodendrocytes via a phosphatidylinositol 3-kinase-dependent pathway. J Neurosci 23:4208-4218.
61. Sun H, Lesche R, Li DM, Liliental J, Zhang H, Gao J, Gavrilova N, Mueller B, Liu X, Wu H. 1999. PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and AKT/protein kinase B signaling pathway. Proc Natl Acad Sci USA 96:6199-6204.
62. Tang DG, Li L, Chopra DP, Porter AT. 1998. Extended survivability of prostate cancer cells in the absence of trophic factors: Increased proliferation, evasion of apoptosis, and the role of apoptosis proteins. Cancer Res 58:3466-3479.
63. Tsou AP, Wu KM, Tsen TY, Chi CW, Chiu JH, Lui WY, Hu CP, Chang C, Chou CK, Tsai SF. 1998. Parallel hybridization analysis of multiple protein kinase genes: Identification of gene expression patterns characteristic of human hepatocellular carcinoma. Genomics 50:331-340.
64. van Bokhoven A, Varella-Garcia M, Korch C, Johannes WU, Smith EE, Miller HL, Nordeen SK, Miller GJ, Lucia MS. 2003. Molecular characterization of human prostate carcinoma cell lines. Prostate 57:205-225.
65. Varnum BC, Young C, Elliott G, Garcia A, Bartley TD, Fridell YW, Hunt EW, Trail G, Clogston C, Toso RJ, et al. 1995. Axl receptor tyrosine kinase stimulated by the vitamin K-dependent protein encoded by growth-arrest-specific gene 6. Nature 373:623-626.
66. Vlietstra RJ, Van Alewijk DC, Hermans KG, Van Steenbrugge GJ, Trapman J. 1998. Frequent inactivation of PTEN in prostate cancer cell lines and xenografts. Cancer Res 58:2720-2723.
67. Webber MM, Quader ST, Kleinman HK, Bello-DeOcampo D, Storto PD, Bice G, DeMendonca-Calaca W, Williams DE. 2001. Human cell lines as an in vitro/in vivo model for prostate carcinogenesis and progression. Prostate 47:1-13.
68. Whang YE, Wu X, Suzuki H, Reiter RE, Tran C, Vessella RL, Said JW, Isaacs WB, Sawyers CL. 1998. Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression. Proc Natl Acad Sci USA 95:5246-5250.